Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Zhu Y, Liu Z, Qu Y, Zeng J, et al. YLZ-F5, a novel polo-like kinase 4 inhibitor, inhibits human ovarian cancer cell growth by inducing apoptosis and mitotic defects. Cancer Chemother Pharmacol 2020 Jun 9. pii: 10.1007/s00280-020-04098.
PMID: 32519033


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016